These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8558918

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A cultured malignant B-1 line serves as a model for Richter's syndrome.
    Peng B, Sherr DH, Mahboudi F, Hardin J, Wu YH, Sharer L, Raveché ES.
    J Immunol; 1994 Aug 15; 153(4):1869-80. PubMed ID: 8046247
    [Abstract] [Full Text] [Related]

  • 23. Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts.
    Al-Katib AM, Smith MR, Kamanda WS, Pettit GR, Hamdan M, Mohamed AN, Chelladurai B, Mohammad RM.
    Clin Cancer Res; 1998 May 15; 4(5):1305-14. PubMed ID: 9607591
    [Abstract] [Full Text] [Related]

  • 24. The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.
    Al-Katib AM, Mensah-Osman E, Aboukameel A, Mohammad R.
    Semin Oncol; 2003 Apr 15; 30(2):313-7. PubMed ID: 12720160
    [Abstract] [Full Text] [Related]

  • 25. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M, Moretti L, Terenzi A, Bazzucchi F, Del Papa B, Bazzucchi M, Ciurnelli R, Lucchesi A, Sportoletti P, Rosati E, Marconi PF, Falzetti F, Tabilio A.
    Cytotherapy; 2009 Apr 15; 11(1):86-96. PubMed ID: 19153855
    [Abstract] [Full Text] [Related]

  • 26. Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia.
    Bacher U, Haferlach T, Schnittger S, Weiss T, Burkhard O, Bechtel B, Kern W, Haferlach C.
    Cancer Genet Cytogenet; 2010 Jul 15; 200(2):170-4. PubMed ID: 20620602
    [Abstract] [Full Text] [Related]

  • 27. A human B-cell CLL model established by transplantation of JOK-1 cells into SCID mice and an anti-leukemia efficacy of fludarabine phosphate.
    Bai L, Kon K, Tatsumi M, Ito H, Hayashi S, Brautigam M.
    Oncol Rep; 2000 Jul 15; 7(1):33-8. PubMed ID: 10601587
    [Abstract] [Full Text] [Related]

  • 28. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line.
    Pu QQ, Bezwoda WR.
    Anticancer Res; 2000 Jul 15; 20(4):2569-78. PubMed ID: 10953328
    [Abstract] [Full Text] [Related]

  • 29. A cell culture system that mimics chronic lymphocytic leukemia cells microenvironment for drug screening and characterization.
    Natoni A, O'Dwyer M, Santocanale C.
    Methods Mol Biol; 2013 Jul 15; 986():217-26. PubMed ID: 23436415
    [Abstract] [Full Text] [Related]

  • 30. Interphase cytogenetic abnormalities in chronic lymphocytic leukemia may predict response to rituximab.
    Byrd JC, Smith L, Hackbarth ML, Flinn IW, Young D, Proffitt JH, Heerema NA.
    Cancer Res; 2003 Jan 01; 63(1):36-8. PubMed ID: 12517774
    [Abstract] [Full Text] [Related]

  • 31. The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement.
    Melo JV, Foroni L, Brito-Babapulle V, Luzzatto L, Catovsky D.
    Clin Exp Immunol; 1988 Jul 01; 73(1):23-8. PubMed ID: 3262465
    [Abstract] [Full Text] [Related]

  • 32. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
    Cordone I, Matutes E, Catovsky D.
    Leukemia; 1992 Sep 01; 6(9):902-6. PubMed ID: 1387694
    [Abstract] [Full Text] [Related]

  • 33. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM, Wall NR, Dutcher JA, Al-Katib AM.
    Clin Cancer Res; 2000 Dec 01; 6(12):4950-6. PubMed ID: 11156256
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The vascular endothelial growth factor receptor tyrosine kinase inhibitors vatalanib and pazopanib potently induce apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
    Paesler J, Gehrke I, Gandhirajan RK, Filipovich A, Hertweck M, Erdfelder F, Uhrmacher S, Poll-Wolbeck SJ, Hallek M, Kreuzer KA.
    Clin Cancer Res; 2010 Jul 01; 16(13):3390-8. PubMed ID: 20570929
    [Abstract] [Full Text] [Related]

  • 36. DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
    Willmore E, Elliott SL, Mainou-Fowler T, Summerfield GP, Jackson GH, O'Neill F, Lowe C, Carter A, Harris R, Pettitt AR, Cano-Soumillac C, Griffin RJ, Cowell IG, Austin CA, Durkacz BW.
    Clin Cancer Res; 2008 Jun 15; 14(12):3984-92. PubMed ID: 18559621
    [Abstract] [Full Text] [Related]

  • 37. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T, Lech-Maranda E, Robak P.
    Expert Rev Anticancer Ther; 2010 Oct 15; 10(10):1529-43. PubMed ID: 20942624
    [Abstract] [Full Text] [Related]

  • 38. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
    Kawata A, Yoshida M, Okazaki M, Yokota S, Barcos M, Seon BK.
    Cancer Res; 1994 May 15; 54(10):2688-94. PubMed ID: 8168098
    [Abstract] [Full Text] [Related]

  • 39. Genetic and immunophenotypic profile of IGH@ rearrangement detected by fluorescence in situ hybridization in 149 cases of B-cell chronic lymphocytic leukemia.
    Lu G, Kong Y, Yue C.
    Cancer Genet Cytogenet; 2010 Jan 01; 196(1):56-63. PubMed ID: 19963136
    [Abstract] [Full Text] [Related]

  • 40. Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL.
    Hofbauer JP, Heyder C, Denk U, Kocher T, Holler C, Trapin D, Asslaber D, Tinhofer I, Greil R, Egle A.
    Leukemia; 2011 Sep 01; 25(9):1452-8. PubMed ID: 21606964
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.